Triple‐negative breast cancer (TNBC) is a highly malignant subtype of breast cancer (BC), which is defined by the lack of expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast carcinoma.